BioWorld MedTech

Dec. 16, 2013

BioVentrix expands European trial of Revivent-TC via LIVE procedure

An implant intended to address the cause of heart failure that was once implanted during an open-chest procedure in the operating room is now being delivered via a less invasive technique in the catheter lab in a European clinical trial. Read More

Mindray moves upmarket with Zonare acquisition

International report: Echo grants rights to MTIA for Symphony CGM in China

Washington Roundup: Budget bill offers language for medical device tax repeal

Sundance will expand psychiatric evaluation

Grants: Ixico wins grant competition in UK for dementia products

Financings roundup: Xoma to sell common stock in public offering

Med-Tech Notes

People in Places

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...